Prediction and prevention of pregnancy-induced hypertensive disorders

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 13, Issue 1, 1999, Pages 131-156

  Visser, Willy ^a   Wallenburg, Henk C S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin II sensitivity; Calcium; Doppler ultrasound; Fibronectin; Low dose aspirin; Pre eclampsia; Prediction; Pregnancy induced hypertension; Prevention; Urinary kallikrein creatinine ratio

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; KETANSERIN; LABETALOL; METHYLDOPA; NIFEDIPINE; NITRIC OXIDE DONOR; RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE; TISSUE KALLIKREIN; WARFARIN;

ANURIA; BONE DEFECT; BRADYCARDIA; CALCIUM INTAKE; COLOR ULTRASOUND FLOWMETRY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG SAFETY; FEMALE; FETUS DISEASE; FETUS MORTALITY; HIGH RISK PATIENT; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATIENT COMPLIANCE; PLACENTA CIRCULATION; PREDICTION; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; SOLUTIO PLACENTAE; VERY LOW BIRTH WEIGHT;

ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; CREATININE; DIET; FEMALE; FIBRONECTINS; FORECASTING; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TISSUE KALLIKREINS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL;

EID: 0043282091     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.1999.0011     Document Type: Article

References (192)

1. Abramowicz JS, Warsof SL, Shere MD et al (1991) Value of random single Doppler study of the umbilical artery for predicting perinatal outcome. Journal of Ultrasound in Medicine 10: 337-339.
2. Ahmed Y, Van Iddekinge B, Paul C et al (1993) Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. British Journal of Obstetrics and Gynaeology 100: 216-220.
3. D'Almeida A, Carter JP, Anatol A & Prost C (1992) Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women and Health 19: 117-131.
4. Altura BM, Altura BT & Carella A (1983) Magnesium deficiency-induced spasm of umbilical vessels: relation to pre-eclampsia, hypertension, growth retardation. Science 221: 376-378.
5. Appel LJ, Moore TJ, Obarzanek E et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 336: 1117-1124.
6. Arduini D, Rizzo G, Romanini C & Mancuso S (1987) Utero-placental blood flow velocity waveforms as predictors of pregnancy-induced hypertension. European Journal of Obstetrics and Gynecology and Reproductive Biology 26: 335-341.
7. Ashour AMN, Lieberman ES, Wilkins Haug LE & Repke JT (1997) The value of elevated second-trimester β-human chorionic gonadotropin in predicting development of preeclampsia. American Journal of Obstetrics and Gynecology 176: 438-442.
8. Atkinson MW, Maher JE, Owen J et al (1994) The predictive value of umbilical artery Doppler studies for preeclampsia or fetal growth retardation in a preeclampsia prevention trial. Obstetrics and Gynecology 83: 609-612.
9. Baker PN & Hackett GA (1994)The use of urinary albumin-creatinine ratios and calcium-creatinine ratios as screening tests for pregnancy-induced hypertension. Obstetrics and Gynecology 83: 745-749.
10. Baker PN & Johnson IR (1994) The use of the hand-grip test for predicting pregnancy-induced hypertension. European Journal of Obstetrics and Gynecology and Reproductive Biology 56: 169-172.
11. Baker PN, Broughton Pipkin F & Symonds EM (1990) Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clinical Science 79: 403-408.
12. Baker PN, Broughton Pipkin F & Symonds M (1991) Platelet angiotensin II binding sites in normotensive and hypertensive women. British Journal of Obstetrics and Gynaecology 98: 436-440.
13. Baker PN, Broughton Pipkin F & Symonds EM (1992a) Longitudinal study of platelet angiotensin II binding in human pregnancy. Clinical Science 82: 377-381.
14. Baker PN, Broughton Pipkin F & Symonds EM (1992b) Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension. Clinical Science 83: 89-95.
15. Baker PN, Kilby MD & Broughton Pipkin F (1992c) The effect of angiotensin II on platelet intracellular free calcium concentration in human pregnancy. Journal of Hypertension 10: 55-60.
16. Ballegeer V, Spitz B, Kieckens L et al (1989) Predictive value of increased plasma levels of fibronectin in gestational hypertension. American Journal of Obstetrics and Gynecology 161: 432-436.
17. DuBard MB, Goldenberg RL, Copper RL & Hauth JC (1993) Are pill counts valid measures of compliance in clinical obstetric trials? American Journal of Obstetrics and Gynecology 169: 1181-1182.
18. Barr SM, Lees KR, Butters L et al (1989) Platelet intracellular free calcium concentration in normotensive and hypertensive pregnancies in the human. Clinical Science 76: 67-71.
19. Belizan JM, Villar J & Repke J (1988)The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. American Journal of Obstetrics and Gynecology 158: 898-902.
20. Benedetto C, Marozio L, Giarola M et al (1998) Twenty-four hour blood pressure monitoring in early pregnancy: is it predictive of pregnancy-induced hypertension and preeclampsia? Acta Obstetricia et Gynecologica Scandinavica 77: 14-21.
21. *Bewley S, Cooper D & Campbell S (1991) Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre-eclampsia and intrauterine growth retardation. British Journal of Obstetrics and Gynaecology 98: 871-879.
22. Blekta M, Hlavaty V, Trnkova M et al (1970) Volume of whole blood and absolute amount of serum proteins in the early stage of late toxemia of pregnancy. American Journal of Obstetrics and Gynecology 106: 10-13.
23. *Bower S, Bewley S & Campbell S (1993a) Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstetrics and Gynecology 82: 78-83.
24. Bower S, Schuchter K & Campbell S (1993b) Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation. British Journal of Obstetrics and Gynaecology 100: 989-994.
25. Branch DW, Silver RM, Blackwell JL et al (1992) Outcome of treated pregnancies in women with anti-phospholipid syndrome: an update of the Utah experience. Obstetrics and Gynecology 80: 614-620.
26. Brazerol WF, Grover S & Donnenfeld AE (1994) Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. American Journal of Obstetrics and Gynecology 171: 1030-1035.
27. Bremer HA & Wallenburg HCS (1992) Aspirin in pregnancy. Fetal and Maternal Medicine Review 4: 37-57.
28. Bucher HC, Guyatt GH, Cook RJ et al (1996) Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. Journal of the American Medical Association 275: 1113-1117.
29. Bulstra-Ramakers MTE, Huisjes HJ & Visser GHA (1995) The effects of 3 g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 102: 123-126.
30. Butters L, Kennedy S & Rubin PC (1990) Atenolol in essential hypertension during pregnancy. British Medical Journal 301: 587-589.
31. Van Buul BJA, Steegers EAP, Van der Maten GD et al (1997) Dietary sodium restriction does not prevent -gestational hypertension: a Dutch two-center randomized trial. Hypertension in Pregnancy 16: 335-346.
32. Campbell DM, MacGillivray I & Carr-Hill R (1985) Pre-eclampsia in second pregnancy. British Journal of Obstetrics and Gynaecology 92: 131-140.
33. Campbell S, Diaz-Recasens J, Griffin DR et al (1983) New Doppler technique for assessing uteroplacental blood flow. Lancet 1: 675-677.
34. Campbell S, Pearce JMF, Hackett G et al (1986) Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstetrics and Gynecology 68: 649-653.
35. *Caritis S, Sibai B, Hauth J et al (1998) Low-dose aspirin to prevent preeclampsia in women at high risk. New England Journal of Medicine 338: 701-705.
36. Chesley LC (1972) Plasma and red cell volumes during pregnancy. American Journal of Obstetrics and Gynecology 112: 440-450.
37. *CLASP Collaborative Group (1994) CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343: 619-629.
38. CLASP Collaborative Group (1995) Low-dose aspirin in pregnancy and early childhood development: follow-up of the collaborative low-dose aspirin study in pregnancy. British Journal of Obstetrics and Gynaecology 102:861-868.
39. Collins R (1994) Antiplatelet agents for IUGR and pre-eclampsia. In Enkin MW, Keirse MJNC, Renfrew MJ & Neilson JP (eds) Cochrane Database of Systematic Reviews, Issue I. Oxford: Update Software.
40. *Collins R & Wallenburg HCS (1989) Pharmacological prevention and treatment of hypertensive disorders in pregnancy. In Chalmers I, Enkin M & Keirse MJNC (eds) Effective Care in Pregnancy and Childbirth, vol. I, pp 512-533. Oxford: Oxford University Press.
41. *Conde-Agudelo A, Lede R & Belizán J (1994) Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. Obstetrical and Gynecological Survey 49: 210-222.
42. Conde-Agudelo A, Belizán JM, Lede R & Bergel EF (1993) What does an elevated mean arterial pressure in the second half of pregnancy predict - gestational hypertension or preeclampsia? American Journal of Obstetrics and Gynecology 169: 509-514.
43. Conradt A, Weidinger H & Algayer H (1984) On the role of magnesium in fetal hypotrophy, pregnancy-induced hypertension, and pre-eclampsia. Magnesium-Bulletin 2: 68-76.
44. Crandon AJ & Isherwood DM (1979) Effect of aspirin on incidence of pre-eclampsia. Lancet 1: 1356.
45. Cruickshank DJ, Campbell D, Robertson AA & MacGillivray I (1992) Intra-uterine growth retardation and maternal labetalol treatment in a random allocation controlled study. Journal of Obstetrics and Gynaecology 12: 223-227.
46. Degani S, Abinader E, Eibschitz I et al (1985) Isometric exercise test for predicting gestational hypertension. Obstetrics and Gynecology 65: 652-654.
47. Dekker GA (1995) The pharmacological prevention of pre-eclampsia. In Ballière's Clinical Obstetrics and Gynaecology, vol. 9, pp 509-528. London: Baillière Tindall.
48. Dekker GA & Sibai BM (1993) Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. American Journal of Obstetrics and Gynecology 168: 214-227.
49. Dekker GA & Van Geijn HP (1996) Endothelial dysfunction in preeclampsia. Part II: reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives. Journal of Perinatal Medicine 24: 119-139.
50. Dekker GA, Makovitz JW & Wallenburg HCS (1990) Prediction of pregnancy-induced hypertensive disorders by angiotensin II sensitivity and supine presser test. British Journal of Obstetrics and Gynaecology 97: 817-821.
51. Department of Health, Welsh Office, Scottish Home and Health Department & Department of Health and Social Services, Northern Ireland (1994) Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1978-1988, pp 22-33. London: HMSO.
52. Dieckmann WJ & Michel HL (1937) Vascular-renal effects of posterior pituitary extracts in pregnant women. American Journal of Obstetrics and Gynecology 33: 131-137.
53. Duley L (1992) Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. British Journal of Obstetrics and Gynaecology 99: 547-553.
54. Duley L (1995) Diuretics for prevention of pre-eclampsia. In Keirse MJNC, Renfrew MJ, Neilson JP & Crowther C (eds) Cochrane Database of Systematic Reviews, Issue 2. Oxford: Update Software.
55. Dyerberg J (1986) Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutrition Reviews 44: 125-134.
56. Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345: 1455-1463.
57. ECPPA Collaborative Group (1996) ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. British Journal of Obstetrics and Gynaecology 103:39-47.
58. Ekholm E, Erkkola R & Hartiala J (1994) Comparison of cardiovascular reflex tests and blood pressure measurement in prediction of pregnancy-induced hypertension. European Journal of Obstetrics and Gynecology and Reproductive Biology 54: 37-41.
59. Van den Elzen HJ, Wladimiroff JW, Cohen Overbeek TE et al (1995) Calcium metabolism, calcium supplementation and hypertensive disorders of pregnancy. European Journal of Obstetrics and Gynecology and Reproductive Biology 59: 5-16.
60. Fay RA, Bromham DR, Brooks JA et al (1985) Platelet and uric acid in the prediction of preeclampsia. American Journal of Obstetrics and Gynecology 152: 1038-1089.
61. Ferrier C, North RA, Becker G et al (1994) Uterine artery waveform as a predictor of pregnancy outcome in women with underlying renal disease. Clinical Nephrology 42: 362-368.
62. FitzGerald DJ, Entman SS, Mulloy K & FitzGerald GA (1987) Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 75: 956-963.
63. Gallery EDM, Hunyor SN & Györy AZ (1979) Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Quarterly Journal of Medicine 48: 593-602.
64. Gallery EDM, Ross MR, Hawkins M et al (1997) Low-dose aspirin in high-risk pregnancy? Hypertension in Pregnancy 16: 229-238.
65. Gant NF, Daley GL, Chand S et al (1973) A study of angiotensin II presser response throughout primigravid pregnancy. Journal of Clinical Investigation 52: 2682-2689.
66. Gold RB, Marinoff DN, Brubaker DB et al (1991) Prediction of pregnancy-induced hypertension with two methods of fibronectin measurement. American Journal of Obstetrics and Gynecology 164: 274 (abstract).
67. Gordon YB, Grudzinskas JG, Kitau MJ et al (1978) Fetal wastage as a result of an alpha-fetoprotein screening programme. Lancet 1: 677-678.
68. Grant JM (1996) Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required. British Journal of Obstetrics and Gynaecology 103: 599-602.
69. Grunewald C (1997) Biochemical prediction of pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica (supplement) 164: 104-107.
70. Haller H, Oeney T, Hauck U et al (1989) Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. American Journal of Hypertension 2: 238-243.
71. Hamilton MP, Abdalla HI & Whitfield CR (1985) Significance of raised maternal serum alfa-fetoprotein in singleton pregnancies with normally formed fetuses. Obstetrics and Gynecology 65: 465-470.
72. Hanretty KP, Primrose M, Neilson JP & Whittle MJ (1989) Pregnancy screening by Doppler uteroplacental and umbilical artery waveforms. British Journal of Obstetrics and Gynaecology 96: 1163-1167.
73. Hargood JL & Brown MA (1991) Pregnancy-induced hypertension: recurrence rate in second pregnancies. Medical Journal of Australia 154: 376-377.
74. Harrington K, Cooper D, Lees C et al (1996) Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstetrics and Gynecology 7: 182-188.
75. Hauth JC, Goldenberg RL, Parker CR Jr et al (1993) Low-dose aspirin therapy to prevent preeclampsia. American Journal of Obstetrics and Gynecology 168: 1083-1093.
76. Hauth JC, Goldenberg RL, Parker GR Jr et al (1995a) Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality. Obstetrics and Gynecology 85: 1055-1058.
77. 2 reduction versus pregnancy outcome in a low-dose aspirin trial. American Journal of Obstetrics and Gynecology 173: 578-584.
78. Hays PM, Cruikshank DP & Dunn LJ (1985) Plasma volume determination in normal and preeclamptic pregnancies. American Journal of Obstetrics and Gynecology 151: 958-966.
79. Hermida RC, Ayala DE, Mojón A et al (1998) Blood pressure excess for the early identification of gestational hypertension and preeclampsia. Hypertension 31 (part I): 83-89.
80. Higgins JR, Walshe JJ, Halligan A et al (1997) Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? British Journal of Obstetrics and Gynaecology 104: 356-362.
81. Hsu CD, Chan DW, Iriye B et al (1994) Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. American Journal of Obstetrics and Gynecology 170: 1135-1138.
82. Huikeshoven FJM & Zuijderhoudt FM (1990) Hypocalciuria in hypertensive disorder in pregnancy and how to measure it. European Journal of Obstetrics and Gynecology and Reproductive Biology 36: 81-85.
83. Hunt IF, Murphy NJ, Cleaver AE et al (1984) Zinc supplementation during pregnancy: effects on selected blood constituents and on progress and outcome of pregnancy in low income women of Mexican descent. American Journal of Clinical Nutrition 40: 508-521.
84. Imperiale TF & Petrulis AS (1991) A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. Journal of the American Medical Association 266: 260-264.
85. Jacobson S, Imhof R, Manning N et al (1990) The value of Doppler assessment of the uteroplacental circulation in predicting preeclampsia or intrauterine growth retardation. American Journal of Obstetrics and Gynecology 162: 110-114.
86. Janes SL, Kyle PM, Redman C & Goodall AH (1995) Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thrombosis and Haemostasis 74: 1059-1063.
87. Jønsson B, Hauge B, Larsen MF & Hald F (1996) Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica 75: 725-729.
88. Josten LE, Savik K, Mullett SE et al (1995) Bedrest compliance for women with pregnancy problems. Birth 22: 1-12.
89. Kaaja R, Hiilesmaa V, Holma K & Jarvenpaa AL (1992) Maternal antihypertensive therapy with beta-blockers associated with poor outcome in very-low-birthweight infants. International Journal of Gynaecology and Obstetrics 38: 195-199.
90. Kilby MD, Broughton Pipkin F, Cockbill S et al (1990) A cross-sectional study of basal platelet intracellular free calcium concentration in normotensive and hypertensive primigravid pregnancies. Clinical Science 78: 75-80.
91. Konijnenberg A, van der Post JAM, Mol BW et al (1997) Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. American Journal of Obstetrics and Gynecology 177: 434-442.
92. Kramer MS (1994a) Regular aerobic exercise during pregnancy. In Enkin MW, Keirse MJNC, Renfrew MJ & Neilson JP (eds) Cochrane Database of Systematic Reviews, Issue I. Oxford: Update Software.
93. Kramer MS (1994b) Balanced protein/energy supplementation in pregnancy. In Enkin MW, Keirse MJNC, Renfrew MJ & Neilson JP (eds) Cochrane Database of Systematic Reviews, Issue I. Oxford: Update Software.
94. Kramer MS (1994c) Isocaloric balanced protein supplementation in pregnancy. In Enkin MW, Keirse MJNC, Renfrew MJ & Neilson JP (eds) Cochrane Database of Systematic Reviews, Issue I. Oxford: Update Software.
95. Kramer MS (1994d) Energy, protein restriction in pregnant women with high weight-for-height or weight gain. In Enkin MW, Keirse MJNC, Renfrew MJ & Neilson JP (eds) Cochrane Database of Systematic Reviews, Issue I. Oxford: Update Software.
96. Kyle PM & Redman CWG (1992) Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. Drug Safety 7: 223-234.
97. Kyle PM, Redman C, de Swiet M & Millar G (1997) A comparison of the inactive urinary kallikrein:creatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia. Authors' reply. British Journal of Obstetrics and Gynaecology 104: 971.
98. Kyle PM, Clark SJ, Buckley D et al (1993) Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? British Journal of Obstetrics and Gynaecology 100: 914-919.
99. Kyle PM, Buckley D, Kissane J et al (1995a) The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy. American Journal of Obstetrics and Gynecology 173: 865-872.
100. Kyle PM, Jackson MC, Buckley DC et al (1995b) Platelet intracellular free calcium response to arginine vasopressin is similar in preeclampsia and normal pregnancy. American Journal of Obstetrics and Gynecology 172: 654-660.
101. *Kyle PM, Campbell S, Buckley D et al (1996) A comparison of the inactive urinary kallikreinxreatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia. British Journal of Obstetrics and Gynaecology 103:981-987.
102. Leitich H, Egarter C, Husslein P et al (1997) A meta-analysis of low-dose aspirin for the prevention of intrauterine growth retardation. British Journal of Obstetrics and Gynaecology 104: 450-459.
103. *Levine RJ, Hauth JC, Curet LB et al (1997) Trial of calcium to prevent preeclampsia. New England Journal of Medicine 337: 69-76.
104. Lewis R, Belfort M & Sibai B (1996) The role of calcium channel blockers in the treatment of women with pre-eclampsia. Fetal and Maternal Medicine Review 8: 19-27.
105. Lind AR & McNicol GW (1967) Circulatory responses to sustained hand-grip concentrations performed during other exercise, both rhythmic and static. Journal of Physiology 192: 595-607.
106. Linjer E & Hansson L (1997) Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error. Journal of Hypertension 15: 221-225.
107. + cellular fibronectin precede the clinical signs of preeclampsia. American Journal of Obstetrics and Gynecology 162: 358-362.
108. MacGillivray I (1958) Some observations on the incidence of pre-eclampsia. Journal of Obstetrics and Gynaecology of the British Empire 64: 536-539.
109. MacGillivray I (1983) Functional pathology of pre-eclampsia. In Pre-eclampsia. The Hypertensive Disease of Pregnancy, pp 56-163. London: W B. Saunders.
110. Magann EF & Martin JN Jr (1995) The laboratory evaluation of hypertensive gravidas. Obstetrical and Gynecological Survey 50: 138-145.
111. Mahomed K, James DK, Golding J & McCabe R (1989) Zinc supplementation during pregnancy: a double blind randomised controlled trial. British Medical Journal 299: 826-830.
112. Mardones-Santander F, Rosso P, Stekel A et al (1988) Effect of milk-based food supplement on maternal nutritional status and fetal growth in underweight Chilean women. American Journal of Clinical Nutrition 47:413-419.
113. Marya RK, Rathee S & Mittal R (1988) Evaluation of three clinical tests for predicting pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 158: 683-684.
114. Van der Maten GD, van Raaij JMA, Visman L et al (1997) Low-sodium diet in pregnancy: effects on blood pressure and maternal nutritional status. British Journal of Nutrition 77: 703-720.
115. McCaw-Binns A (1996) Low dose aspirin in pregnancy - are there any benefits? In Abstract Book 10th World Congress of the ISSHP, Seattle, WA, p 76.
116. McGiff JC & Carroll MA (1994) Eicosanoids in preeclampsia-eclampsia: the effects of magnesium. Hypertension in Pregnancy 13: 217-226.
117. McParland P & Pearce JM (1988) Doppler blood flow in pregnancy. Placenta 9: 427-450.
118. Millar JGB, Campbell SK, Albano JDM et al (1996) Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample. British Journal of Obstetrics and Gynaecology 103: 421-426.
119. Milunsky A, Jick SS, Bruell CL et al (1989) Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. American Journal of Obstetrics and Gynecology 161:219-297.
120. Moodley J & Norman RJ (1989) Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia. Prostaglandins, Leukotrienes and Essential Fatty Acids 37: 145-147.
121. Morris JA, O'Grady JP, Hamilton CJ & Davidson EC (1978) Vascular reactivity to angiotensin II infusion during gestation. American Journal of Obstetrics and Gynecology 130: 379-384.
122. Moutquin JM, Rainville C, Giroux L et al (1985) A prospective study of blood pressure in pregnancy: prediction of preeclampsia. American Journal of Obstetrics and Gynecology 151: 191-196.
123. Murphy JF, O'Riordan J, Newcombe RG et al (1986) Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1: 992-995.
124. Nakamura T, Ito M, Matsui K et al (1986) Significance of angiotensin sensitivity test for prediction of pregnancy-induced hypertension. Obstetrics and Gynecology 67: 388-394.
125. Newnham JP, Patterson LL, James IR et al (1990) An evaluation of the efficacy of Doppler flow velocity waveform analysis as a screening test in pregnancy. American Journal of Obstetrics and Gynecology 162: 403-410.
126. Nisell H, Hjemdahl P & Linde B (1985) Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clinical Physiology 5: 479-493.
127. Nisell H, Larsson G & Wager L (1989) The relation between life stress and hypertensive complications during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 68: 423-427.
128. North RA, Ferrier C, Long D et al (1994) Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstetrics and Gynecology 83: 378-386.
129. North RA, Ferrier C, Gamble G et al (1995) Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Australian and New Zealand Journal of Obstetrics and Gynaecology 35: 357-362.
130. O'Grady JP, Hamilton C, Moris JA & Davidson EC (1977) Sequential evaluation of the supine hypertension or 'roll-over' test in a high risk population. Gynecologic Investigation 8: 282-287.
131. Okonofua FE, Onwudiegwu U, Odunsi AO et al (1990) Does standing up improve the predictive value of the supine pressor test for gestational hypertension? Obstetrics and Gynecology 76: 332-335.
132. Olsen SF & Secher NJ (1990) A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia; indications from a 50-year-old controlled trial. British Journal of Nutrition 64: 599-609.
133. Olsen S, Sørensen JD, Secher NL et al (1992) Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339: 1003-1007.
134. Oney T & Kaulhausen H (1982) The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy. American Journal of Obstetrics and Gynecology 142: 17-20.
135. Onwude JL, Lilford RJ, Hjartardottir H et al (1995) A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. British Journal of Obstetrics and Gynaecology 102: 95-100.
136. Orozco JZ, Pinsker VS, Hernández J & Karchmer S (1979) Valor de la prueba de la angiotensina II y del'roll over test' como métodos predictives de la enfermedad hipertensiva aguda del embarazo (preeclampsia y eclampsia). Ginecologia y Obstetricia de Mexico 46: 235-244.
137. Paarlberg KM, De Jong CLD, Van Geijn HP et al (1998) Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study. Obstetrics and Gynecology 91: 383-388.
138. Patrono C (1994) Aspirin as an antiplatelet drug. New England Journal of Medicine 330: 1287-1294.
139. Phuapradit W, Manusook S & Lolekha P (1993) Urinary calcium/creatinine ratio in the prediction of preeclampsia. Austalian and New Zealand Journal of Obstetrics and Gynaecology 33: 280-281.
140. Pickles CJ, Symonds EM & Broughton Pipkin F (1989) The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 96: 38-43.
141. Piper JM, Ray WA & Rosa FW (1992) Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstetrics and Gynecology 80: 429-432.
142. Raab W, Schroeder G, Wagner R & Gigee W (1956) Vascular reactivity and electrolytes in normal and toxemic pregnancy. Journal of Clinical Endocrinology 16: 1196-1216.
143. Raniolo E & Phillipou G (1993) Prediction of pregnancy-induced hypertension by means of the urinary calcium:creatinine ratio. Medical Journal of Australia 158: 98-100.
144. Redman CWG (1991) Controlled trials of antihypertensive drugs in pregnancy. American Journal of Kidney Diseases 17: 149-153.
145. Redman CWG, Beilin LJ, Bonnar J & Ounsted MK (1976) Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 2: 753-756.
146. Redman CWG, Williams GF, Jones DD & Wilkinson RH (1977) Plasma urate and serum deoxycytidylate deaminase measurements for the early diagnosis of preeclampsia. British Journal of Obstetrics and Gynaecology 84: 904-908.
147. Report of a Workshop (1996) Where next for prophylaxis against pre-eclampsia? British Journal of Obstetrics and Gynaecology 103: 603-607.
148. Roberts JM, Taylor RN, Musci TJ et al (1989) Preeclampsia: an endothelial cell disorder. American Journal of Obstetrics and Gynecology 161:1200-1204.
149. Rodriquez MH, Masaki DI, Mestman J et al (1988) Calcium/creatinine ratio and microalbuminuria in the prediction of preeclampsia. American Journal of Obstetrics and Gynecology 159: 1452-1455.
150. Rotchell YE, Cruickshank JK, Phillips-Gay M et al (1998) Barbados low-dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. British Journal of Obstetrics and Gynaecology 105: 286-292.
151. Said ME, Campbell DM, Azzam ME & MacGillivray I (1984) β-Human chorionic gonadotropin levels before and after the development of pre-eclampsia. British Journal of Obstetrics and Gynaecology 91: 772-775.
152. Sanchez-Ramos L, Jones DC & Cullen MT (1991) Urinary calcium as an early marker for pre-eclampsia. Obstetrics and Gynecology 77: 685-688.
153. Schiff E & Mashiach S (1992) The use of low dose aspirin in pregnancy. American Journal of Reproductive Immunology 28: 153-156.
154. Schulman H, Winter D, Farmakides G et al (1989) Pregnancy surveillance with Doppler velocimetry in uterine and umbilical arteries. American Journal of Obstetrics and Gynecology 160: 192-196.
155. Sen C, Madazh R, Kavuzlu C et al (1994) The value of antithrombin-II and fibronectin in hypertensive disorders of pregnancy. Journal of Perinatal Medicine 22: 29-38.
156. Sibai BM (1996) Treatment of hypertension in pregnant women. New England Journal of Medicine 335: 257-265.
157. Sibai BM, El-Nazer A & Gonzalez-Ruiz A (1986) Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. American Journal of Obstetrics and Gynecology 155: 1011-1016.
158. Sibai BM, Villar MA & Bray E (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 161: 115-119.
159. Sibai BM, Mercer B & Sarinoglu C (1991) Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. American Journal of Obstetrics and Gynecology 165: 1408-1412.
160. Sibai BM, Gonzalez AR, Mabie WC & Moretti M (1987) A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstetrics and Gynecology 70: 323-327.
161. Sibai BM, Mabie WC, Shamsa F et al (1990) A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. American Journal of Obstetrics and Gynecology 162: 960-967.
162. Sibai BM, Caritis SN, Thom E et al (1993) Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. New England Journal of Medicine 329: 1213-1218.
163. Smith G & Smith OW (1948) Internal secretions and toxemia of late pregnancy. Physiological Reviews 28: 1-22.
164. Sørensen JD, Olsen SF, Pedersen AK et al (1993) Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology 168:915-922.
165. Spätling L & Spätling G (1988) Magnesium supplementation in pregnancy. A double-blind study. British Journal of Obstetrics and Gynaecology 95: 120-125.
166. Steegers EAP, Eskes TKAB, Jongsma HW & Hein PR (1991a) Dietary sodium restriction during pregnancy: a historical review. European Journal of Obstetrics and Gynecology and Reproductive Biology 40: 83-90.
167. Steegers EAP, van Lakwijk HPJM, Jongsma HW et al (1991b) (Patho) physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study. British Journal of Obstetrics and Gynaecology 98: 980-987.
168. *Steyn DW & Odendaal HJ (1997) Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 350: 1267-1271.
169. Stubbs TM, Lazarchick J, Miller MC et al (1991) Plasma fibronectin: not a useful early marker for preeclampsia. American Journal of Obstetrics and Gynecology 164: 277.
170. Talledo OE (1966) Renin-angiotensin system in normal and toxemic pregnancies. I. Angiotensin infusion test. American Journal of Obstetrics and Gynecology 96: 141-143.
171. Talledo OE, Chesley LC & Zuspan FP (1968) Renin-angiotensin system in normal and toxemic pregnancies. III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. American Journal of Obstetrics and Gynecology 100: 218-221.
172. Taufield PA, Ales KL, Resnick LM et al (1987) Hypocalciuria in preeclampsia. New England Journal of Medicine 316:715-718.
173. Taylor RN, Crombleholme WR, Friedman SA et al (1991) High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. American Journal of Obstetrics and Gynecology 165: 895-901.
174. Thornton JG, Molloy BJ, Vinall PS et al (1989) A prospective study of haemostatic tests at 28 weeks gestation as predictors of pre-eclampsia and growth retardation. Thrombosis and Haemostasis 61: 243-245.
175. Tomoda S, Kitanaka T, Ogita S & Hidaka A (1994) Prediction of pregnancy-induced hypertension by isometric exercise. Asia-Oceania Journal of Obstetrics and Gynaecology 20: 249-255.
176. Vaillant P, David E, Constant I et al (1996) Validity in nulliparas of increased β-human chorionic gonatrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intra-uterine growth retardation. Nephron 72: 557-563.
177. Viinikka L, Hartikainen-Sorri AL, Lumme R et al (1993) Low-dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. British Journal of Obstetrics and Gynaecology 100: 809-815.
178. Visser W & Wallenburg HCS (1991) Central hemodynamic observations in untreated preeclamptic patients. Hypertension 17: 1072-1077.
179. Visser W & Wallenburg HCS (1997) Prospective assessment of the recurrence risk of preeclampsia. Hypertension in Pregnancy 16: 128.
180. *Wallenburg HCS (1989) Detecting hypertensive disorders of pregnancy. In Chalmers I, Enkin M & Keirse MJNC (eds) Effective Care in Pregnancy and Childbirth, vol. 1, pp 382-402. Oxford: Oxford University Press.
181. Wallenburg HCS (1995) Low-dose aspirin in obstetrics. Current Opinion in Obstetrics and Gynecology 7: 135-139.
182. Wallenburg HCS & Bremer HA (1992) Principles and applications of manipulation of prostaglandin synthesis in pregnancy. In Baillière's Clinical Obstetrics and Gynaecology, vol. 6, pp 859-891. London: Baillière Tindall.
183. Wallenburg HCS & Visser W (1994) Pregnancy-induced hypertensive disorders. Current Opinion in Obstetrics and Gynecology 6: 19-29.
184. Wallenburg HCS, Dekker GA, Makovitz JW & Rotmans P (1986) Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1: 1-3.
185. Weber C, Erl W, Pietsch A & Weber PC (1995) Aspirin inhibits nuclear factor-kappa B mobilization and mono-cyte adhesion in stimulated human endothelial cells. Circulation 91: 1914-1917.
186. Weitz C, Khouzami V, Maxwell K & Johnson JWC (1987) Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. International Journal of Gynaecology and Obstetrics 25: 35-40.
187. Williams MA, Hickok DE, Zingheim RW et al (1992) Elevated maternal serum alpha-fetoprotein levels in mid-trimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology 167: 1032-1037.
188. Working Group (1990) National high blood pressure education program working group report on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 163: 1689-1712.
189. Zemel MB & Zemel PC (1992) Platelet calcium metabolism in the prediction of pre-eclampsia. New England Journal of Medicine 326: 647.
190. Zemel MB, Zemel PC, Berry S et al (1990) Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. New England Journal of Medicine 323: 434-438.
191. Zuspan FP & Ward MC (1964) Treatment of eclampsia. Southern Medical Journal 57: 954-959.
192. Zuspan FP, Nelson GH & Ahlquist RP (1964) Epinephrine infusions in normal and toxemic pregnancy. I. Nonesterified fatty acids and cardiovascular alterations. American Journal of Obstetrics and Gynecology 90: 88-96.